The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
Abstract
Selective growth of T lymphocytes occurred when unfractionated normal human bone marrow cells were cultured with conditioned medium obtained from phytohemagglutinin-stimulated normal human lymphocytes (Ly-CM). Cultures of up to 90 percent T cells have been maintained for more than 9 months. The T cells exhibited a strict growth dependence upon Ly-CM and were consistently negative for Epstein-Barr viral information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reedman, B. M., & Klein, G. (1973) · International Journal of Cancer · doi:10.1002/ijc.2910110302 · Cited by 1,668
(1972) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/49.3.891 · Cited by 916
Cited by
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043
Self-citationPopovic, M., Sarngadharan, M. G., Read, E., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200935 · Cited by 3,535
Self-citationZhang, Y., & Zhang, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,794
Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., Skibber, J. M., Shiloni, E., Vetto, J. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132327 · Cited by 2,653
Adoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
Interleukin-2: Inception, Impact, and Implications
Smith, K. A. (1988) · Science · doi:10.1126/science.3131876 · Cited by 2,153
Atkins, M. B., Lotze, M. T., Dutcher, J. P., Fisher, R. I., Weiss, G., Margolin, K., Abrams, J., Sznol, M., Parkinson, D., Hawkins, M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2105 · Cited by 2,048
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovic, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,807
Self-citationThe role of interleukin-2 during homeostasis and activation of the immune system
Boyman, O., & Sprent, J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3156 · Cited by 1,657
Collins, S. J., Ruscetti, F. W., Gallagher, R. E., & Gallo, R. C. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.5.2458 · Cited by 1,594
Self-citationIsolation of a New Virus, HBLV, in Patients with Lymphoproliferative Disorders
Salahuddin, S. Z., Ablashi, D. V., Markham, P. D., Josephs, S. F., Sturzenegger, S., Kaplan, M., Halligan, G., Biberfeld, P., Wong-Staal, F., Kramarsky, B., et al. (1986) · Science · doi:10.1126/science.2876520 · Cited by 1,428
Self-citationA Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Sanmamed, M. F., & Chen, L. (2018) · Cell · doi:10.1016/j.cell.2018.09.035 · Cited by 1,392
Long term culture of tumour-specific cytotoxic T cells
GILLIS, S., & SMITH, K. A. (1977) · Nature · doi:10.1038/268154a0 · Cited by 1,386
IL-2: The First Effective Immunotherapy for Human Cancer
Rosenberg, S. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1490019 · Cited by 1,289
KINO, T., HATANAKA, H., HASHIMOTO, M., NISHIYAMA, M., GOTO, T., OKUHARA, M., KOHSAKA, M., AOKI, H., & IMANAKA, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1249 · Cited by 1,241
KINO, T., HATANAKA, H., MIYATA, S., INAMURA, N., NISHIYAMA, M., YAJIMA, T., GOTO, T., OKUHARA, M., KOHSAKA, M., AOKI, H., et al. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1256 · Cited by 1,209
Collins, S. (1987) · Blood · doi:10.1182/blood.v70.5.1233.1233 · Cited by 1,190
Rosenberg, S. A. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510360033032 · Cited by 1,131
History of lectins: from hemagglutinins to biological recognition molecules
Sharon, N. (2004) · Glycobiology · doi:10.1093/glycob/cwh122 · Cited by 1,128
Malek, T. R. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090357 · Cited by 1,079
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Liao, W., Lin, J.-X., & Leonard, W. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.01.004 · Cited by 1,075
T cell growth factor receptors. Quantitation, specificity, and biological relevance
Robb, R., Munck, A., & Smith, K. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.154.5.1455 · Cited by 1,061
New insights into the regulation of T cells by γc family cytokines
Rochman, Y., Spolski, R., & Leonard, W. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2580 · Cited by 1,053
Signaling and Function of Interleukin-2 in T Lymphocytes
Ross, S. H., & Cantrell, D. A. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053352 · Cited by 975
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
Lenardo, M., Chan, F. K.-M., Hornung, F., McFarland, H., Siegel, R., Wang, J., & Zheng, L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.221 · Cited by 943
The Interleukin-2 T-Cell System: A New Cell Growth Model
Cantrell, D. A., & Smith, K. A. (1984) · Science · doi:10.1126/science.6427923 · Cited by 922
Akdis, M., Aab, A., Altunbulakli, C., Azkur, K., Costa, R. A., Crameri, R., Duan, S., Eiwegger, T., Eljaszewicz, A., Ferstl, R., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.033 · Cited by 912
Smith, K. A. (1980) · Immunological Reviews · doi:10.1111/j.1600-065x.1980.tb00327.x · Cited by 897
Leonard, W. J., Depper, J. M., Uchiyama, T., Smith, K. A., Waldmann, T. A., & Greene, W. C. (1982) · Nature · doi:10.1038/300267a0 · Cited by 864
Interleukin-1 Stimulation of Astroglial Proliferation After Brain Injury
Giulian, D., & Lachman, L. B. (1985) · Science · doi:10.1126/science.3872478 · Cited by 855
Molecular cloning and expression of cDNAs for the human interleukin-2 receptor
Leonard, W. J., Depper, J. M., Crabtree, G. R., Rudikoff, S., Pumphrey, J., Robb, R. J., Krönke, M., Svetlik, P. B., Peffer, N. J., Waldmann, T. A., et al. (1984) · Nature · doi:10.1038/311626a0 · Cited by 850
Tolerance, not immunity, crucially depends on IL-2
Malek, T. R., & Bayer, A. L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1435 · Cited by 820
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
The IL-2/IL-2 receptor system: A current overview
Taniguchi, T. (1993) · Cell · doi:10.1016/0092-8674(93)90152-g · Cited by 761
Poiesz, B. J., Ruscetti, F. W., Reitz, M. S., Kalyanaraman, V. S., & Gallo, R. C. (1981) · Nature · doi:10.1038/294268a0 · Cited by 756
Self-citationNashan, B., Moore, R., Amlot, P., Schmidt, A.-G., Abeywickrama, K., & Soulillou, J.-P. (1997) · The Lancet · doi:10.1016/s0140-6736(97)09278-7 · Cited by 749
Liao, W., Lin, J.-X., & Leonard, W. J. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.08.003 · Cited by 745
Rosenberg, S. A., Mulé, J. J., Spiess, P. J., Reichert, C. M., & Schwarz, S. L. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.1169 · Cited by 745
Inflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
The cytokine network involved in the host immune response to periodontitis
Pan, W., Wang, Q., & Chen, Q. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0064-z · Cited by 696
Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism
Cullen, B. R. (1986) · Cell · doi:10.1016/0092-8674(86)90696-3 · Cited by 681
Hatakeyama, M., Tsudo, M., Minamoto, S., Kono, T., Doi, T., Miyata, T., Miyasaka, M., & Taniguchi, T. (1989) · Science · doi:10.1126/science.2785715 · Cited by 677
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.
Bacher, M., Metz, C. N., Calandra, T., Mayer, K., Chesney, J., Lohoff, M., Gemsa, D., Donnelly, T., & Bucala, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7849 · Cited by 664
The functional relationship of the interleukins.
Smith, K. A., Lachman, L. B., Oppenheim, J. J., & Favata, M. F. (1980) · The Journal of experimental medicine · doi:10.1084/jem.151.6.1551 · Cited by 653
Biology and regulation of IL-2: from molecular mechanisms to human therapy
Spolski, R., Li, P., & Leonard, W. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0046-y · Cited by 637
Chung, K. F., & Barnes, P. J. (1999) · Thorax · doi:10.1136/thx.54.9.825 · Cited by 638
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
Klatzmann, D., & Abbas, A. K. (2015) · Nature Reviews Immunology · doi:10.1038/nri3823 · Cited by 636
IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
Ahmadzadeh, M., & Rosenberg, S. A. (2006) · Blood · doi:10.1182/blood-2005-06-2399 · Cited by 632
Human T-lymphotropic retroviruses
Wong-Staal, F., & Gallo, R. C. (1985) · Nature · doi:10.1038/317395a0 · Cited by 612
Self-citationTransient expression of interleukin 2 receptors. Consequences for T cell growth.
Cantrell, D. A., & Smith, K. A. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.6.1895 · Cited by 607
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.
Krönke, M., Leonard, W. J., Depper, J. M., Arya, S. K., Wong-Staal, F., Gallo, R. C., Waldmann, T. A., & Greene, W. C. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.16.5214 · Cited by 605
Self-citationResponse of resting human peripheral blood natural killer cells to interleukin 2.
Trinchieri, G., Matsumoto-Kobayashi, M., Clark, S. C., Seehra, J., London, L., & Perussia, B. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.4.1147 · Cited by 604
The IL-2 Receptor Complex: Its Structure, Function, and Target Genes
Minami, Y., Kono, T., Miyazaki, T., & Taniguchi, T. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001333 · Cited by 604
The Soluble Interleukin-2 Receptor: Biology, Function, and Clinical Application
Rubin, L. A., & Nelson, D. L. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-8-619 · Cited by 602
Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coli
Rosenberg, S. A., Grimm, E. A., McGrogan, M., Doyle, M., Kawasaki, E., Koths, K., & Mark, D. F. (1984) · Science · doi:10.1126/science.6367046 · Cited by 595
Blattner, W. A., Kalyanaraman, V. S., Robert‐Guroff, M., Lister, T. A., Galton, D. A. G., Sarin, P. S., Crawford, M. H., Catovsky, D., Greaves, M., & Gallo, R. C. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910300302 · Cited by 578
Self-citationMolecular cloning of cDNA encoding human interleukin-2 receptor
Nikaido, T., Shimizu, A., Ishida, N., Sabe, H., Teshigawara, K., Maeda, M., Uchiyama, T., Yodoi, J., & Honjo, T. (1984) · Nature · doi:10.1038/311631a0 · Cited by 565
Tagaya, Y., Maeda, Y., Mitsui, A., Kondo, N., Matsui, H., Hamuro, J., Brown, N., Arai, K., Yokota, T., & Wakasugi, H. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03436.x · Cited by 562
Isolation and Transmission of Human Retrovirus (Human T-Cell Leukemia Virus)
Popovic, M., Sarin, P. S., Robert-Gurroff, M., Kalyanaraman, V. S., Mann, D., Minowada, J., & Gallo, R. C. (1983) · Science · doi:10.1126/science.6600519 · Cited by 559
Self-citationRole of IL-2 in cancer immunotherapy
Jiang, T., Zhou, C., & Ren, S. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1163462 · Cited by 549
Tumor Immunology and Tumor Evolution: Intertwined Histories
Galon, J., & Bruni, D. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.018 · Cited by 540
Continuous proliferation of murine antigen-specific helper T lymphocytes in culture.
Watson, J. (1979) · The Journal of experimental medicine · doi:10.1084/jem.150.6.1510 · Cited by 517
NetPath: a public resource of curated signal transduction pathways
Kandasamy, K., Mohan, S. S., Raju, R., Keerthikumar, S., Kumar, G. S. S., Venugopal, A. K., Telikicherla, D., Navarro, J. D., Mathivanan, S., Pecquet, C., et al. (2010) · Genome Biology · doi:10.1186/gb-2010-11-1-r3 · Cited by 505
Meuer, S. C., Hussey, R. E., Cantrell, D. A., Hodgdon, J. C., Schlossman, S. F., Smith, K. A., & Reinherz, E. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1509 · Cited by 495
Biology of the Interleukin-2 Receptor
Nelson, B. H., & Willerford, D. M. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60386-7 · Cited by 475
Dinarello, C. A., & Mier, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171506 · Cited by 463
Immune Responses in Interleukin-2-Deficient Mice
Kündig, T. M., Schorle, H., Bachmann, M. F., Hengartner, H., Zinkernagel, R. M., & Horak, I. (1993) · Science · doi:10.1126/science.8235625 · Cited by 462
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Hinrichs, C. S., Spolski, R., Paulos, C. M., Gattinoni, L., Kerstann, K. W., Palmer, D. C., Klebanoff, C. A., Rosenberg, S. A., Leonard, W. J., & Restifo, N. P. (2008) · Blood · doi:10.1182/blood-2007-09-113050 · Cited by 462
The Intriguing History of Cancer Immunotherapy
Dobosz, P., & Dzieciątkowski, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02965 · Cited by 458
Targeting cytokine and chemokine signaling pathways for cancer therapy
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01868-3 · Cited by 455
Waldmann, T. A. (1986) · Science · doi:10.1126/science.3008337 · Cited by 453
Neckers, L. M., & Cossman, J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.11.3494 · Cited by 447
T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells.
Isakson, P. C., Puré, E., Vitetta, E. S., & Krammer, P. H. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.3.734 · Cited by 442
Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas
Gazdar, A., Carney, D., Bunn, P., Russell, E., Jaffe, E., Schechter, G., & Guccion, J. (1980) · Blood · doi:10.1182/blood.v55.3.409.409 · Cited by 442
Overview of interleukin-2 function, production and clinical applications
GAFFEN, S., & LIU, K. (2004) · Cytokine · doi:10.1016/j.cyto.2004.06.010 · Cited by 431
Prostaglandin E inhibits the production of human interleukin 2.
Rappaport, R. S., & Dodge, G. R. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.3.943 · Cited by 421
Cross, S. L., Feinberg, M. B., Wolf, J. B., Holbrook, N. J., Wong-Staal, F., & Leonard, W. J. (1987) · Cell · doi:10.1016/0092-8674(87)90754-9 · Cited by 414
Interleukin 2 regulates its own receptors.
Smith, K. A., & Cantrell, D. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.864 · Cited by 406
Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration
Wada, Y., Nakashima, O., Kutami, R., Yamamoto, O., & Kojiro, M. (1998) · Hepatology · doi:10.1002/hep.510270214 · Cited by 405
HUMAN T CELL LEUKEMIA VIRUS TYPE I (HTLV-I) AND HUMAN DISEASES
Uchiyama, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.15 · Cited by 392
LICHTMAN, M., SPIVAK, J., BOXER, L., SHATTIL, S., & HENDERSON, E. (2000) · Hematology · doi:10.1016/b978-012448510-5/50140-0 · Cited by 392
(2010) · Advances in Cancer Research · doi:10.1016/s0065-230x(10)07003-x · Cited by 386
The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications
Leonard, W. J., Lin, J.-X., & O'Shea, J. J. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.028 · Cited by 383
Hatakeyama, M., Mori, H., Doi, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90607-7 · Cited by 360
Factors Affecting B-Cell Growth and Differentiation
Kishimoto, T. (1985) · Annual Review of Immunology · doi:10.1146/annurev.iy.03.040185.001025 · Cited by 359
Interleukin-2: Biology, Design and Application
Arenas-Ramirez, N., Woytschak, J., & Boyman, O. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.10.003 · Cited by 359
Engineering IL-2 for immunotherapy of autoimmunity and cancer
Hernandez, R., Põder, J., LaPorte, K. M., & Malek, T. R. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00680-w · Cited by 355
Clinical effects and toxicity of interleukin-2 in patients with cancer
Lotze, M. T., Matory, Y. L., Rayner, A. A., Ettinghausen, S. E., Vetto, J. T., Seipp, C. A., & Rosenberg, S. A. (1986) · Cancer · doi:10.1002/1097-0142(19861215)58:12<2764::aid-cncr2820581235>3.0.co;2-z · Cited by 355
Burgess, A. W. (1985) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1985.tb00868.x · Cited by 351
Waldmann, T. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49895-x · Cited by 345
Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus.
Popovic, M., Lange-Wantzin, G., Sarin, P. S., Mann, D., & Gallo, R. C. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5402 · Cited by 342
Self-citationThe role of CD8+ T‐cell replicative senescence in human aging
Effros, R. B., Dagarag, M., Spaulding, C., & Man, J. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00259.x · Cited by 336
Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion?
Effros, R. B., & Pawelec, G. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01079-7 · Cited by 336
TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCER
Kradin, R., Lazarus, D., Dubinett, S., Gifford, J., Grove, B., Kurnick, J., Preffer, F., Pinto, C., Davidson, E., Callahan, R., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91609-7 · Cited by 336
A Pathogenic Retrovirus (HTLV-III) Linked to AIDS
Broder, S., & Gallo, R. C. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411153112006 · Cited by 335
Self-citationAltman, A., Theofilopoulos, A. N., Weiner, R., Katz, D. H., & Dixon, F. J. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.791 · Cited by 331
Both integrated and differential regulation of components of the IL-2/IL-2 receptor system
Kim, H. P., Imbert, J., & Leonard, W. J. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.07.003 · Cited by 325
Natural history and therapy of metastatic renal cell carcinoma: The role of interleukin-2
Bukowski, R. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971001)80:7<1198::aid-cncr3>3.0.co;2-h · Cited by 325
Wang, A., Lu, S.-D., & Mark, D. F. (1984) · Science · doi:10.1126/science.6427925 · Cited by 324
Metadata
- Authors
- Morgan, D. A., Ruscetti, F. W., & Gallo, R.
- Venue
- Science
- Published
- 1976-09-10
- Volume
- 193
- Issue
- 4257
- Pages
- 1007-1008
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2051962533
- Cited by
- 2,493
- References
- 2
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.